Hemochromatosis: Revisiting an Old Disease – A Case Report
Article Sidebar
Main Article Content
Abstract
Abstract
Introduction: Hemochromatosis is part of hereditary diseases that cause iron overload, aUecting the liver, pancreas, endocrine glands, and heart, leading to organ dysfunction.
Case presentation: A 51-year-old male with a history of insulin-dependent diabetes mellitus, hypogonadotropic hypogonadism, and seronegative arthritis presents with a condition of overall health deterioration, hematemesis, and melena lasting 24 hours. Laboratory tests compatible with diabetic ketoacidosis are requested, and treatment with fluid resuscitation and insulin is initiated, with good progress. To investigate the decompensating factor, a contrast-enhanced CT scan of the chest, abdomen, and pelvis is performed, revealing multifocal pneumonia, as well as Chronic Liver Disease (CLD) with esophageal varices and moderate splenomegaly. Following this incidental finding, a study for CLD was initiated, and ferritin levels were recorded as > 1200 ng/ml. the high suspicion for hemochromatosis, an MRI of the liver for iron quantification, liver biopsy, and genetic testing are requested.
Discussion: The diagnosis of hereditary hemochromatosis requires a high level of suspicion, as it lacks specific symptoms or signs and usually presents asymptomatically. Transferrin saturation and ferritin tests are helpful, but the definitive diagnosis is made through iron concentration measurement via Magnetic Resonance Imaging (MRI) or liver biopsy. In this patient, the iron overload not only caused liver cirrhosis but is also inferred to be part of the origin of diabetes mellitus, hypogonadotropic hypogonadism, and joint involvement. The treatment is therapeutic phlebotomy, which improves symptoms and reduces morbidity and mortality if started early.
Downloads
Article Details
Copyright (c) 2025 Rojas DG, et al.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Licensing and protecting the author rights is the central aim and core of the publishing business. Peertechz dedicates itself in making it easier for people to share and build upon the work of others while maintaining consistency with the rules of copyright. Peertechz licensing terms are formulated to facilitate reuse of the manuscripts published in journals to take maximum advantage of Open Access publication and for the purpose of disseminating knowledge.
We support 'libre' open access, which defines Open Access in true terms as free of charge online access along with usage rights. The usage rights are granted through the use of specific Creative Commons license.
Peertechz accomplice with- [CC BY 4.0]
Explanation
'CC' stands for Creative Commons license. 'BY' symbolizes that users have provided attribution to the creator that the published manuscripts can be used or shared. This license allows for redistribution, commercial and non-commercial, as long as it is passed along unchanged and in whole, with credit to the author.
Please take in notification that Creative Commons user licenses are non-revocable. We recommend authors to check if their funding body requires a specific license.
With this license, the authors are allowed that after publishing with Peertechz, they can share their research by posting a free draft copy of their article to any repository or website.
'CC BY' license observance:
|
License Name |
Permission to read and download |
Permission to display in a repository |
Permission to translate |
Commercial uses of manuscript |
|
CC BY 4.0 |
Yes |
Yes |
Yes |
Yes |
The authors please note that Creative Commons license is focused on making creative works available for discovery and reuse. Creative Commons licenses provide an alternative to standard copyrights, allowing authors to specify ways that their works can be used without having to grant permission for each individual request. Others who want to reserve all of their rights under copyright law should not use CC licenses.
Olynyk JK, Ramm GA. Hemochromatosis. N Engl J Med. 2022;387(23):2159-2170. Available from: https://doi.org/10.1056/nejmra2119758
Griffiths WJH. Hemochromatosis. Medicine (Abingdon). 2023;51(6):412–417. Available from: https://doi.org/10.1016/j.mpmed.2023.01.010
Pietrangelo A. Hereditary hemochromatosis. Biochim Biophys Acta. 2006;1763(7):700–710. Available from: https://doi.org/10.1016/j.bbamcr.2006.05.013
Online Mendelian Inheritance in Man. Available from: http://www.ncbi.nlm.nih.gov/omim/
Kato J, Fujikawa K, Kanda M, Fukuda N, Sasaki K, Takayama T, et al. A mutation in the iron-responsive element of H ferritin mRNA, causing autosomal dominant iron overload. Am J Hum Genet. 2001;69(1):191–197. Available from: https://doi.org/10.1086/321261
Wohllk N, Zapata R, Acuña M, Reyes H, Navarro A, Roa I, et al. HFE gene mutations in Chile. Ann Intern Med. 2003;139(8):708–709. Available from: https://doi.org/10.7326/0003-4819-139-8-200310210-00029
Powell LW, Seckington RC, Deugnier Y. Haemochromatosis. Lancet. 2016;388(10000):706–716. Available from: https://doi.org/10.1016/s0140-6736(15)01315-x
Pietrangelo A, Caleffi A, Corradini E. Non-HFE hepatic iron overload. Semin Liver Dis. 2011;31(3):302–318. Available from: https://doi.org/10.1055/s-0031-1286061
Wallace DF, Subramaniam VN. Non-HFE haemochromatosis. World J Gastroenterol. 2007;13(35):4690–4698. Available from: http://dx.doi.org/10.3748/wjg.v13.i35.4690
Kane SF, Roberts C, Paulus R. Hereditary Hemochromatosis: Rapid Evidence Review. Am Fam Physician. 2021;104(3):263–270. Available from: https://www.aafp.org/afp/2021/0801/p263.html
Aronow WS. Tratamiento de la hemocromatosis cardíaca. Arch Cienc Med. 2018;14(3):560–568. Available from: https://doi.org/10.5114/aoms.2017.68729
El Osta R, Grandpre N, Monnin N, Hubert J, Koscinski I. Hypogonadotropic hypogonadism in men with hereditary hemochromatosis. Basic Clin Androl. 2017;27:13. Available from: https://doi.org/10.1186/s12610-017-0057-8
European Association for the Study of the Liver. EASL Clinical Practice Guidelines on haemochromatosis. J Hepatol. 2022;77(2):479–502. Available from: https://doi.org/10.1016/j.jhep.2022.03.033
Kowdley KV, Brown KE, Ahn J, Sundaram V. ACG Clinical Guideline: Hereditary Hemochromatosis. Am J Gastroenterol. 2019;114(8):1202–1218. Available from: https://doi.org/10.14309/ajg.0000000000000315